CA2837695C - Reduced coenzyme q10 crystal having excellent stability - Google Patents
Reduced coenzyme q10 crystal having excellent stability Download PDFInfo
- Publication number
- CA2837695C CA2837695C CA2837695A CA2837695A CA2837695C CA 2837695 C CA2837695 C CA 2837695C CA 2837695 A CA2837695 A CA 2837695A CA 2837695 A CA2837695 A CA 2837695A CA 2837695 C CA2837695 C CA 2837695C
- Authority
- CA
- Canada
- Prior art keywords
- reduced coenzyme
- crystal
- coenzyme
- crystalline solid
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
- C07C46/10—Separation; Purification; Stabilisation; Use of additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/34—Separation; Purification; Stabilisation; Use of additives
- C07C41/40—Separation; Purification; Stabilisation; Use of additives by change of physical state, e.g. by crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/34—Separation; Purification; Stabilisation; Use of additives
- C07C41/46—Use of additives, e.g. for stabilisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
- C07C45/81—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
- C07C49/577—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011-141028 | 2011-06-24 | ||
| JP2011141028 | 2011-06-24 | ||
| PCT/JP2012/065869 WO2012176842A1 (ja) | 2011-06-24 | 2012-06-21 | 安定性に優れた還元型補酵素q10結晶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2837695A1 CA2837695A1 (en) | 2012-12-27 |
| CA2837695C true CA2837695C (en) | 2019-12-31 |
Family
ID=47422673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2837695A Active CA2837695C (en) | 2011-06-24 | 2012-06-21 | Reduced coenzyme q10 crystal having excellent stability |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9388109B2 (en:Method) |
| EP (1) | EP2725004B1 (en:Method) |
| JP (1) | JP5998135B2 (en:Method) |
| KR (1) | KR101991143B1 (en:Method) |
| CN (1) | CN103635452B (en:Method) |
| AU (1) | AU2012274434B2 (en:Method) |
| BR (1) | BR112013032641B1 (en:Method) |
| CA (1) | CA2837695C (en:Method) |
| DK (1) | DK2725004T3 (en:Method) |
| ES (1) | ES2668675T3 (en:Method) |
| TW (1) | TWI568718B (en:Method) |
| WO (1) | WO2012176842A1 (en:Method) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201613561A (en) * | 2014-02-17 | 2016-04-16 | Kaneka Corp | Composition comprising reduced coenzyme q10 |
| US10561667B2 (en) | 2015-07-24 | 2020-02-18 | Shenzhen Zhenxing Medical Technology Co., Ltd. | Orbit azine-fumarate, hydrate, crystal form and preparation method therefor |
| EP3755683A1 (en) * | 2018-02-23 | 2020-12-30 | Center for Intelligent Research in Crystal Engineering, S.L. | Cocrystals of ubiquinol and compositions comprising them |
| US11453633B2 (en) | 2018-08-30 | 2022-09-27 | Kaneka Corporation | Production method for crystal of reduced coenzyme Q10 having excellent stability |
| JP7389044B2 (ja) * | 2018-09-28 | 2023-11-29 | 株式会社カネカ | 安定性に優れた還元型補酵素q10結晶の製造方法 |
| US11471426B2 (en) | 2019-10-16 | 2022-10-18 | American River Nutrition, Llc | Compositions comprising quinone and/or quinol and methods of preparations and use thereof |
| WO2021161807A1 (ja) | 2020-02-12 | 2021-08-19 | 株式会社カネカ | FormII型の還元型補酵素Q10結晶の製造方法 |
| CN113024362B (zh) * | 2021-03-10 | 2022-02-15 | 中国科学院上海药物研究所 | 一种辅酶qh与烟酰胺的共晶及其制备方法和用途 |
| US20240166589A1 (en) * | 2021-03-26 | 2024-05-23 | Kaneka Corporation | Method for producing form-ii type reduced coenzyme q10 crystal or crystalline solid of same, and crystallizing apparatus |
| JP7695993B2 (ja) * | 2021-03-26 | 2025-06-19 | 株式会社カネカ | FormII型の還元型補酵素Q10結晶又はその結晶性固体の製造方法 |
| US12617744B2 (en) | 2021-03-26 | 2026-05-05 | Kaneka Corporation | Production method for reduced coenzyme Q10 form-II type crystal or crystalline solid thereof |
| WO2023120558A1 (ja) | 2021-12-24 | 2023-06-29 | 株式会社カネカ | 還元型補酵素q10の保存方法 |
| EP4454643A4 (en) | 2021-12-24 | 2025-11-05 | Kaneka Corp | REDUCED Q10 COENZYME PRESERVATION PROCESS |
| US20250195434A1 (en) * | 2022-03-17 | 2025-06-19 | Kaneka Corporation | Method for preserving solid composition that contains form ii type crystals of reduced coenzyme q10, and packing that contains said solid composition |
| WO2023176878A1 (ja) * | 2022-03-17 | 2023-09-21 | 株式会社カネカ | 還元型補酵素Q10のFormII型結晶を含有する固体組成物の保存方法及び前記固体組成物を含有する梱包体 |
| WO2023176871A1 (ja) | 2022-03-17 | 2023-09-21 | 株式会社カネカ | 還元型補酵素Q10のFormII型結晶を含有する固体組成物 |
| JPWO2024204380A1 (en:Method) * | 2023-03-30 | 2024-10-03 | ||
| JPWO2024204381A1 (en:Method) | 2023-03-30 | 2024-10-03 | ||
| CN117736076B (zh) * | 2023-12-19 | 2025-07-01 | 新开利安生物科技(海南)有限公司 | 一种还原型辅酶q10晶体及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3889481B2 (ja) | 1996-08-16 | 2007-03-07 | 株式会社カネカ | 医薬組成物 |
| JP4577674B2 (ja) | 2000-03-03 | 2010-11-10 | リコーエレメックス株式会社 | 商品企画開発システム、商品企画開発方法および商品企画開発プログラムを記録したコンピュータ読み取り可能な記録媒体 |
| JP4170657B2 (ja) | 2001-07-13 | 2008-10-22 | 株式会社カネカ | 還元型補酵素q10の結晶化法 |
| TWI310029B (en:Method) | 2001-07-13 | 2009-05-21 | Kaneka Corp | |
| TWI237018B (en) | 2001-07-13 | 2005-08-01 | Kaneka Corp | Method of producing reduced coenzyme Q10 crystals |
| EP1408024B1 (en) * | 2001-07-13 | 2010-10-20 | Kaneka Corporation | METHOD OF CRYSTALLIZING REDUCED COENZYME Q sb 10 /sb FROM AQUEOUS SOLUTION |
| TWI235146B (en) | 2001-07-16 | 2005-07-01 | Kaneka Corp | Method of stabilizing reduced coenzyme q10 and method of acidic crystallization |
| TWI329510B (en) | 2001-10-10 | 2010-09-01 | Kaneka Corp | Method of stabilizing reduced coenzyme q10 |
| WO2004063131A1 (en) * | 2003-01-10 | 2004-07-29 | Kaneka Corporation | Method of purifying reduced coenzyme q |
| US7358402B2 (en) * | 2003-09-10 | 2008-04-15 | Kaneka Corporation | Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal |
| KR20060130016A (ko) * | 2003-09-10 | 2006-12-18 | 가부시키가이샤 가네카 | 안정성이 우수한 환원형 보효소 q10 결정 및 환원형보효소 q10 결정을 함유하는 조성물 |
| US20090088574A1 (en) | 2005-12-21 | 2009-04-02 | Eisai R&D Management Co., Ltd. | Crystal of 1,2-dihydropyridine compound (type iv) |
| DE102009059343A1 (de) | 2009-12-31 | 2011-07-07 | Muhr und Bender KG, 57439 | Federelement als offenes Wellenband |
-
2012
- 2012-06-21 CA CA2837695A patent/CA2837695C/en active Active
- 2012-06-21 WO PCT/JP2012/065869 patent/WO2012176842A1/ja not_active Ceased
- 2012-06-21 ES ES12802693.7T patent/ES2668675T3/es active Active
- 2012-06-21 EP EP12802693.7A patent/EP2725004B1/en active Active
- 2012-06-21 DK DK12802693.7T patent/DK2725004T3/en active
- 2012-06-21 CN CN201280031157.XA patent/CN103635452B/zh active Active
- 2012-06-21 AU AU2012274434A patent/AU2012274434B2/en active Active
- 2012-06-21 KR KR1020147001594A patent/KR101991143B1/ko active Active
- 2012-06-21 US US14/129,003 patent/US9388109B2/en active Active
- 2012-06-21 JP JP2013521617A patent/JP5998135B2/ja active Active
- 2012-06-21 BR BR112013032641-7A patent/BR112013032641B1/pt not_active IP Right Cessation
- 2012-06-22 TW TW101122540A patent/TWI568718B/zh active
-
2016
- 2016-06-14 US US15/181,511 patent/US9556098B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112013032641A2 (pt) | 2017-01-24 |
| EP2725004B1 (en) | 2018-02-28 |
| CA2837695A1 (en) | 2012-12-27 |
| US20140120073A1 (en) | 2014-05-01 |
| JP5998135B2 (ja) | 2016-09-28 |
| DK2725004T3 (en) | 2018-04-16 |
| JPWO2012176842A1 (ja) | 2015-02-23 |
| CN103635452B (zh) | 2017-03-15 |
| AU2012274434B2 (en) | 2016-06-09 |
| KR101991143B1 (ko) | 2019-06-19 |
| WO2012176842A1 (ja) | 2012-12-27 |
| TWI568718B (zh) | 2017-02-01 |
| TW201311635A (zh) | 2013-03-16 |
| US20160289152A1 (en) | 2016-10-06 |
| US9556098B2 (en) | 2017-01-31 |
| CN103635452A (zh) | 2014-03-12 |
| BR112013032641B1 (pt) | 2018-10-30 |
| KR20140061350A (ko) | 2014-05-21 |
| US9388109B2 (en) | 2016-07-12 |
| AU2012274434A1 (en) | 2014-01-09 |
| EP2725004A1 (en) | 2014-04-30 |
| ES2668675T3 (es) | 2018-05-21 |
| EP2725004A4 (en) | 2014-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9556098B2 (en) | Reduced coenzyme Q10 crystal having excellent stability | |
| CN101318889B (zh) | 还原型辅酶q10的稳定方法 | |
| JPWO2003006408A1 (ja) | 酸化防護効果の高い溶媒を用いる還元型補酵素q▲下10▼の製造方法 | |
| JP7330987B2 (ja) | 安定性に優れた還元型補酵素q10結晶の製造方法 | |
| JPWO2007126086A1 (ja) | 還元型補酵素q10の精製方法 | |
| JP4598873B2 (ja) | 含水有機溶媒を用いる還元型補酵素q10の製造方法 | |
| US9440901B2 (en) | Method for producing reduced coenzyme Q10 | |
| WO2020067275A1 (ja) | 安定性に優れた還元型補酵素q10結晶の製造方法 | |
| JP2003089669A (ja) | 還元型補酵素q10の結晶化法 | |
| JP3867927B2 (ja) | 還元型補酵素q10の安定化法 | |
| JP3892881B2 (ja) | 還元型補酵素q10の安定化法 | |
| JP2007332162A (ja) | 酸化防護効果の高い溶媒を用いる還元型補酵素q10の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20170313 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD Year of fee payment: 13 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250430 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250430 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - STANDARD Year of fee payment: 14 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260401 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260401 |